The Investigational Medicinal Product Dossier (IMPD): EU CTA vs. FDA IND: Comparing the Content and Agency Expectations at fremont 2017

7 years ago Posted By : User Ref No: WURUR10234 0
  • Image
  • TypeWebinar
  • Image
  • Location San Diego, California, United States
  • Price
  • Date 24-01-2017
Webinar Title
The Investigational Medicinal Product Dossier (IMPD): EU CTA vs. FDA IND: Comparing the Content and Agency Expectations at fremont 2017
Event Type
Webinar
Webinar Date
24-01-2017
Last Date for Applying
23-01-2017
Location
San Diego, California, United States
Organization Name / Organize By
Compliance4All
Organizing/Related Departments
Healthcare Training
Organization Type
Organization/Company
WebinarCategory
Both (Technical & Non Technical)
WebinarLevel
All (State/Province/Region, National & International)
Related Industries

Education/Teaching/Training/Development

Accounting/Financial/Banking/Insurance

Medical/Healthcare/Hospital

OTHERS

Business Development

Location
San Diego, California, United States

OVERVIEW:

This 90 minute training course will provide your company the opportunity for comprehensive understanding of the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application. Additionally, this webinar covers many related processes sponsors will need to know, as they file for, conduct and close-out effective clinical studies in the U.S. and EU.

Product Id : 501059
Instructor : Robert J. Russell

Why you should attend: 

All sponsors, CROs, Sites and auditors of Clinical Research who are involved in pharmaceutical or biological development need to possess the knowledge and be efficient in completing successful applications for their studies. Knowing what is expected of you and "getting-it-right" the first time, will allow faster development of innovative products.

Areas Covered In the Session:

  • US FDA and EU Agency Orientation / Structure
  • Start –Up and Conducting Clinical Trial Processes
  • Following Product Registration / Licensing Options 
  • Company Strategy- Linking Clinical Trials & Marketing Authorization Applications 
  • Balancing Strategy and Long Term Regulatory Cost & Maintenance
  • IMP Dossier & Comparisons of the US IND to the EU CTA Content 
  • Scientific Advice: Member States vs. Pre-IND Meetings with U.S. FDA
  • Orphan Drugs: EU vs. US Treatment
  • GCP Compliance Inspections
  • Essentially Similar and Generic Products
  • Cross-Agency Interactions: Comparing U.S. FDA and EMA
  • Effective Interactions with the Global Regulatory Healthcare Authorities
  • Helpful Websites

Who will benefit: 

This Webinar will provide invaluable assistance to all personnel in the Pharmaceutical, Biotechnology and CRO industry conducting Clinical Trials including:

  • Sponsor Senior management
  • Project Managers
  • Clinical Trial Heads
  • Medical writers
  • Project Managers
  • CRAs and CRCs
  • QA / Compliance personnel
  • Investigators
  • Clinical Research Scientists
  • QA / QC Auditors and Staff
  • Consultants

IMPORTANT DATE:

Webinar Date: Tuesday, January 24, 2017 | 10:00 AM PST | 01:00 PM EST

Duration: 90 Minutes

Others Details

For more details and updates please visit website

Registration Fees
Available
Registration Fees Details
Visit website
Registration Ways
Email
Phone
Website
Address/Venue
  Online Event  Pin/Zip Code : 94539
Official Email ID
Contact
Event Manager

Netzealous LLC DBA - Compliance4All 161 Mission Falls Lane, Suite 216, Fremont, CA 94539, USA.

[email protected]

     18004479407
   Fax No: 302-288-6884